摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-4-Hexadecyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester | 528852-38-2

中文名称
——
中文别名
——
英文名称
(R)-4-Hexadecyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester
英文别名
tert-butyl (4R)-4-hexadecyl-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
(R)-4-Hexadecyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester化学式
CAS
528852-38-2
化学式
C26H51NO3
mdl
——
分子量
425.696
InChiKey
YXKRKKLKZFRDIH-HSZRJFAPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.8
  • 重原子数:
    30
  • 可旋转键数:
    17
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    38.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    (3Z)-2-Acetylamino-3-octadecen-1-ol as a potent apoptotic agent against HL-60 cells
    摘要:
    (2R,3Z)-,(2R,3E)-,(2S,3Z)和(2S,3E)-2-乙酰氨基-3-十八烯-1-醇,以及(2R)和(2S)-2-乙酰氨基-十八烷-1-醇是通过加纳尔醛(N-Boc-N,O-异丙叉-L-或D-丝氨酸)的维蒂格反应由L-或D-丝氨酸制备的。使用MTT检测法,在人白血病HL-60细胞中测试了这些饱和和不饱和2-乙酰氨基醇的凋亡活性。在新合成的化合物中,顺式异构体的活性最强。尽管它们的结构简单,(2R,3Z)-和(2S,3Z)-2-乙酰氨基-3-十八烯-1-醇的凋亡活性与N-乙酰基-D-赤型鞘氨醇(D-e-C2-Cer,一种已知的凋亡诱导剂)相比仍然很高且相当。它们的凋亡活性顺序为:D-e-C2-Cer≈L-e-C2-Cer≈(2R,3Z)≈(2S,3Z)> (2R,3E)≈(2S,3E⇒(2R))≈(2S)-衍生物。通过琼脂糖凝胶电泳对这些化合物引起的DNA片段化进行了定性分析,发现(2R,3Z)和(2S,3Z)异构体如C2-Cer会引起典型的DNA片段化,而反式和饱和异构体则不会。这些化合物诱导的细胞死亡通过外观特征、促凋性半胱氨酸蛋白酶-3的加工和多聚ADP核糖聚合酶(PARP)的切割进一步确认为凋亡。这些观察结果表明,新合成的化合物(3Z)-2-乙酰氨基-3-十八烯-1-醇在HL-60细胞中具有与C2-Cer相似的特性和诱导凋亡的活性。© 2003 Elsevier Ltd. 保留所有权利。
    DOI:
    10.1016/j.bmc.2003.10.040
  • 作为产物:
    参考文献:
    名称:
    Syntheses of sphingosine-1-phosphate stereoisomers and analogues and Their interaction with EDG receptors
    摘要:
    Sphingosine-1-phosphate (S1P) is considered to be an important regulator of diverse biological processes acting as a natural ligand to EDG receptors. As a preliminary study to develop potent and selective agonist and antagonist for EDG receptors, we report synthesis of S1P stereoisomers and analogues and their binding affinities to EDG-1, -3, and -5. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00893-4
点击查看最新优质反应信息

文献信息

  • [EN] METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS<br/>[FR] PROCÉDÉS POUR LA SYNTHÈSE DE SPHINGOMYÉLINES ET DE DIHYDROSPHINGOMYÉLINES
    申请人:CERENIS THERAPEUTICS HOLDING SA
    公开号:WO2014140787A2
    公开(公告)日:2014-09-18
    The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.
  • Syntheses of sphingosine-1-phosphate stereoisomers and analogues and Their interaction with EDG receptors
    作者:Hyun-Suk Lim、Yong-Seok Oh、Pann-Ghill Suh、Sung-Kee Chung
    DOI:10.1016/s0960-894x(02)00893-4
    日期:2003.1
    Sphingosine-1-phosphate (S1P) is considered to be an important regulator of diverse biological processes acting as a natural ligand to EDG receptors. As a preliminary study to develop potent and selective agonist and antagonist for EDG receptors, we report synthesis of S1P stereoisomers and analogues and their binding affinities to EDG-1, -3, and -5. (C) 2002 Elsevier Science Ltd. All rights reserved.
  • (3Z)-2-Acetylamino-3-octadecen-1-ol as a potent apoptotic agent against HL-60 cells
    作者:Hayato Niiro、Hideki Azuma、Shinsuke Tanago、Kiyohiro Matsumura、Keiji Shikata、Taro Tachibana、Kenji Ogino
    DOI:10.1016/j.bmc.2003.10.040
    日期:2004.1
    (2R,3Z)-, (2R,3E)-, (2S,3Z) and (2S,3E)-2-Acetylamino-3-octadecen-1-ol, and (2R)- and (2S)-2-acetylamino-octadecan-1-ol were prepared using the Wittig olefination of Garner's aldehyde (N-Boc-N,O-isopropylidene-L- or D-serinal) from L- or D-serme. The apoptotic activities of these saturated and unsaturated 2-acetylaminoalcohols were examined in human leukemia HL-60 cells using MTT assay. Among the newly synthesized compounds, the cis-isomers were the most potent. Despite their simple structures, (2R,3Z)- and (2S,3Z)-2-acetylamino-3-octadecen-1-ol showed high and comparable apoptotic activities compared with N-acetyl-D-erythro-sphingosine (D-e-C2-Cer, a well-known inducer of apoptosis). Their apoptotic activities were in the order D-e-C2-Cerapproximate toL-e-C2-Cerapproximate to(2R,3Z)-approximate to(2S,3Z)- > > (2R,3E)-approximate to(2S,3E)-approximate to(2R)-approximate to(2S)-derivative. Qualitative analysis of DNA fragmentation caused by these compounds was conducted using agarose gel electrophoresis, and typical DNA fragmentation was found in the cases of (2R,3Z)- and (2S,3Z)-isomers such as C2-Cer, but not trans and saturated isomers. The morphological features of the cells, the proteolytic processing of pro-caspase-3, and the cleavage of PARP as a result of exogenous treatment with (2R,3Z)- and (2S,3Z)-isomers indicated that cell death induced by these compounds was apoptosis. These observations suggest that these newly synthesized compounds, (3Z)-2-Acetylamino-3-octadecen-1-ol, have similar characteristics and apoptosis-inducing activities against HL-60 cells with C2-Cer. (C) 2003 Elsevier Ltd. All rights reserved.
    (2R,3Z)-,(2R,3E)-,(2S,3Z)和(2S,3E)-2-乙酰氨基-3-十八烯-1-醇,以及(2R)和(2S)-2-乙酰氨基-十八烷-1-醇是通过加纳尔醛(N-Boc-N,O-异丙叉-L-或D-丝氨酸)的维蒂格反应由L-或D-丝氨酸制备的。使用MTT检测法,在人白血病HL-60细胞中测试了这些饱和和不饱和2-乙酰氨基醇的凋亡活性。在新合成的化合物中,顺式异构体的活性最强。尽管它们的结构简单,(2R,3Z)-和(2S,3Z)-2-乙酰氨基-3-十八烯-1-醇的凋亡活性与N-乙酰基-D-赤型鞘氨醇(D-e-C2-Cer,一种已知的凋亡诱导剂)相比仍然很高且相当。它们的凋亡活性顺序为:D-e-C2-Cer≈L-e-C2-Cer≈(2R,3Z)≈(2S,3Z)> (2R,3E)≈(2S,3E⇒(2R))≈(2S)-衍生物。通过琼脂糖凝胶电泳对这些化合物引起的DNA片段化进行了定性分析,发现(2R,3Z)和(2S,3Z)异构体如C2-Cer会引起典型的DNA片段化,而反式和饱和异构体则不会。这些化合物诱导的细胞死亡通过外观特征、促凋性半胱氨酸蛋白酶-3的加工和多聚ADP核糖聚合酶(PARP)的切割进一步确认为凋亡。这些观察结果表明,新合成的化合物(3Z)-2-乙酰氨基-3-十八烯-1-醇在HL-60细胞中具有与C2-Cer相似的特性和诱导凋亡的活性。© 2003 Elsevier Ltd. 保留所有权利。
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英